Idiopathic pulmonary fibrosis slowly turns the lungs stiff and scarred, but researchers may have found why the damage keeps ...

T-797 demonstrates pathogen suppression, lung immune restoration and tissue repair activation, supporting Ongoing Phase 2 trialSequential ...

Scientists think they have discovered the reason pulmonary fibrosis patients get worse and don’t heal. Pulmonary fibrosis leads to scar tissue development in the lungs that persists until patients ...

Researchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take advantage of the body’s natural healing response and how a commonly used drug ...

Researchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take advantage of the body's natural healing response and how a commonly used drug ...

Surgeons at Northwestern Medicine in Chicago were able to keep a critically ill patient alive for 48 hours after removing both of his lungs, the hospital reported last week. The patient, a 33-year-old ...

New Phase 2a clinical trial data suggest that treatment with GRI-0621, an experimental oral therapy from GRI Bio, altered the activity of genes linked to inflammation and lung scarring (fibrosis) in ...

Dr. Joshua K. Sabari explains how surgery, radiation and therapy may reduce lung capacity and shares steps survivors can take to protect their breathing health. In a recent video interview, Dr. Joshua ...

LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for the ...

Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies ...

New data builds on prior results, highlights LTI-03's differentiated approach, and supports the ongoing global Phase 2 RENEW trial AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ...